Navigation Links
Drug Trial Proves Nightmare for British Indian Student

An Indian student who completed a management course here and agreed to be part of a drug trial has been struggling to cope with the effects of the trial and is looking// forward to returning to India.

Navneet Modi, the student, agreed to a drug trial for US testing firm Parexel in March, but is now said to be a pale shadow of his former outgoing self. He is reported to be taking antidepressants and medication to stop his skin itching.

London-based Modi also has problems with his bowels and kidneys and his eyes feel permanently dry. He needs to apply eye drops regularly. Reports say that he may have suffered long-term damage, including malignant lymphoma, which the drug was supposed to cure.

He told the Evening Standard: 'I have memory problems. I can't remember my family. I keep crying for no reason. I feel so unsure about the future.'

Parexel had reportedly paid him almost 4,000 pounds for trials on two previous occasions.

'Parexel has done nothing for us. Parexel has refused to get involved. They wouldn't even pay for the taxi to take us home from hospital,' he said.

Reports say that on the day of the trial, he was the third of the guinea pigs to be injected with TGN1412. It was 8.30 a.m. and he started suffering headaches but was told not to worry. By 9.15 a.m., he felt pressure in his skull and in his back. He says he was given paracetamol for the pain.

By 10.00 a.m. he was slipping in and out of consciousness. Around midnight he was wheeled into Northwick Park's intensive care unit where he was given steroids that his lawyers argue should have been administered almost 16 hours earlier.

(Source: IANS)
'"/>




Page: 1

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Vaccine For Dengue Fever On Trial In Asia-Pacific
3. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
4. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
5. Sex, Race Influence Lung Cancer Trial Participation
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
8. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
9. China Begins Human Trials For HIV/AIDS Drug
10. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
11. HIV/AIDS Vaccine Trial To Be Initiated Soon
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... critical to ensuring high-quality results and maintaining GMP and USP compliance. In a ... in accordance with GMP requirements " these requirements are explained. The challenge ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists ... to quality care can be limited while the desire to conquer breakouts and eliminate ... acne care for every customer online, today released its inaugural survey on the State ...
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
(Date:3/28/2017)... , March 28, 2017 ... consolidated vendor landscape, with the top three companies, namely ... accounting for a significant 49% of the overall market ... report. The vendor landscape is intensely competitive and has ... the overall market. These factors have restricted the entry ...
Breaking Medicine Technology: